The Spectrum

Accelerating Translation of Discoveries into Medicine

February 20, 2019 | La Jolla, California

The inaugural Spectrum symposium proved to be a very successful event, with 200+ foundation representatives, philanthropists, biopharma leaders, healthcare investors and research scientists engaging in important discussions that continue to develop. We believe these new connections and budding relationships will help accelerate the delivery of novel medicines to the patients who are waiting for them.

If you have any follow-up questions, or were unable to attend the event but would like to learn more about the ongoing research efforts at Scripps Research, please contact us at

Keynote Speakers

Our Story

Click here to download a PDF version of the agenda

8:00 – 9:00 a.m.

Registration and Breakfast

9:00 – 9:40 a.m.

Keynote: Peter Schultz, President & CEO, Scripps Research 
A New Model for Biomedical Research Institutes

9:40 – 10:40 a.m.

Scientific Session: Harnessing the Immune System

  • Immuno-oncology Approaches
    • Travis Young, VP, Biologics, Calibr
  • Immune System Regulators
    • Hugh Rosen, Professor, Department of Molecular Medicine, Scripps Research
  • A Regulatory T-Cell Approach to Parkinson’s Disease
    • Sean Joseph, Director, Pharmacology, Calibr
  • Rational Vaccine Strategies
    • Dennis Burton, Co-chair, Department of Immunology and Microbiology, Scripps Research

10:40 – 11:40 a.m.

Scientific Session: Regenerative Medicine and Aging

  • Regenerative Medicine for Osteoarthritis
    • Kristen Johnson, Principal Investigator, Biology, Calibr
  • Novel Approaches to Aging & Age-Related Disease
    • Michael Petrascheck, Associate Professor, Department of Molecular Medicine, Scripps Research
  • Remyelination for Multiple Sclerosis
    • Luke Lairson, Assistant Professor, Department of Chemistry, Scripps Research
  • Regeneration & Repair of the Heart & Lung
    • Michael Bollong, Scripps Fellow, Department of Chemistry, Scripps Research

11:40 a.m. - 12:45 p.m.

Lunch & Keynote: Trevor Mundel, President, Global Health Division, Bill & Melinda Gates Foundation
Found in Translation: How Innovations in Product R&D Can Solve the World’s Toughest Health Challenges

12:45 – 1:45 p.m.

Panel Discussion: The Role of Nonprofits in Accelerating Drug Discovery

Moderator: Chris Walsh, Consulting professor, Stanford University

  • Brian Fiske, Senior VP, Research Programs, Michael J. Fox Foundation
  • Ramy Ibrahim, CMO and VP, Clinical Development, Parker Institute for Cancer Immunotherapy
  • Maria Millan, President and CEO, CIRM
  • Trevor Mundel, President, Global Health Division, Bill & Melinda Gates Foundation
  • Paul Negulescu, Senior VP and Site Head of SD Research, Vertex

1:45 – 2:45 p.m.

Scientific Session: Neglected and Childhood Disease

  • Spread & Evolution of Deadly Pathogens
    • Kristian Andersen, Associate Professor, Department of Immunology and Microbiology, Scripps Research
  • Preventing Malaria
    • Arnab Chatterjee, VP, Medicinal Chemistry, Calibr
  • Novel Drugs for Autism-Spectrum Disorder
    • Gavin Rumbaugh, Associate Professor, Department of Neuroscience, Scripps Research
  • Treatments for Diabetes
    • Nikki (Rogers) Alvarez, Associate Director, Alliances, Calibr

2:45 – 3:00 p.m.


3:00 – 4:00 p.m.

Panel Discussion: Novel Funding Mechanisms for Biomedical Research

Moderator: James Schaeffer, UCLA Innovation Center, President, JMSchaeffer Consulting

  • Dan Burgess, Venture Partner, SV Health Investors
  • Kevin Eastwood, VP, Corporate Development, Calibr
  • Carl Goldfischer, Managing Director, Bay City Capital
  • Kathryn Richmond, Director, The Paul G. Allen Frontiers Group
  • Barbara Sosnowski, VP and Global Head, External R&D Innovation Pharmatherapeutics and WRD External Partnerships, Pfizer

4:00 – 5:00 p.m.

Scientific Session: Novel Therapeutic Strategies

  • Protein Homeostasis: Novel Strategies for Degenerative Diseases
    • Jeff Kelly, Professor, Department of Chemistry, Scripps Research
  • Disease in a Dish for Precision Medicine
    • Kristin Baldwin, Professor, Department of Neuroscience, Scripps Research
  • Directed Remodeling of the Gut Microbiome
    • Reza Ghadiri, Professor, Department of Chemistry, Scripps Research
  • Therapeutics for Addiction Relapse & PTSD
    • Courtney Miller, Associate Professor, Department of Molecular Medicine, Scripps Research

5:00 – 5:30 p.m.

Cocktail Reception

5:30 – 7:30 p.m.

Dinner & Keynote: Eric Topol, Director & Founder, Scripps Research Translational Institute, Executive Vice President, Scripps Research
Deep Medicine


Steering Committee

Herb Boyer, PhD, Co-Founder, Genentech
Tom Daniel, MD, Chairman, Vividion Therapeutics
John Diekman, PhD, Founding Partner, 5AM Ventures
Mikael Dolsten, MD, PhD, President, Worldwide Research and Development, Pfizer
William R. Hearst III, Chair of the Board, Hearst Corporation
Rich Heyman, PhD, Executive Chairman of the Board, Metacrine, Inc.
Rajiv Kaul, Portfolio Manager, Fidelity Investments
Sherry Lansing, Founder, The Sherry Lansing Foundation
Claudia Luttrell, President, The Skaggs Institute for Chemical Biology
John Martin, PhD, Chairman, Gilead Sciences
John Reed, MD, PhD, Head of Global Research and Development, Sanofi
Peter Schultz, PhD, President & CEO, Scripps Research

We gratefully acknowledge the generous support provided by the following:

Hosted and Sponsored by

Gold Sponsors



Silver Sponsors